The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Cyclic vomiting syndrome: a case series and review of the literature
Open accessAbstract
Objective: Cyclic vomiting syndrome (CVS) is under-recognised. Treatment is difficult as the pathophysiology is incompletely understood. We report our experience of treating patients with amitriptyline, and review the literature to summarise symptoms and associated features, epidemiology, potential pathophysiological mechanisms, differential diagnoses and treatment. Design: Consecutive adult patients with CVS were identified during a 5-year period from January 2010 until December 2015. Medical records were reviewed retrospectively, and age and sex of the patient, symptoms, associated features and response to treatment with amitriptyline were recorded. Setting: A luminal gastroenterology clinic at a teaching hospital. Results: Seventeen patients were identified (mean age 29.8 years, 13 (76.5%) female). Five had a history of cannabis use. Duration of symptoms prior to diagnosis ranged from 5 months to 15 years. Fourteen patients commenced amitriptyline, and in eight (57.1%) symptoms either ceased entirely or improved. Review of the literature suggested the prevalence of CVS was 0.5%. Symptoms are stereotypical, with acute episodes of nausea and vomiting, interspersed by periods when the patient is symptom-free. Proposed pathophysiologies include neuroendocrine dysfunction, mutations in mitochondrial DNA and re-intoxication effects from cannabis stored in fat tissues. Treatment during the acute phase is supportive, with rehydration, sedation and antiemetics. Prophylaxis to prevent future attacks with antihistamines, antimigraine drugs, antiepileptics and tricyclic antidepressants may be beneficial. Complete cessation of cannabis smoking should be advised. Conclusions: Diagnosis of CVS is often delayed in adults. Once identified, patients respond well to amitriptyline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Across these studies, 413/600 (70%) of patients reported complete or partial improvement with a decrease in frequency, duration, or severity of CVS symptoms when treated with a TCA, most commonly amitriptyline.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [20]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“There were fourteen studies that included 600 adult and pediatric patients.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Gastroduodenal Disorders
Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., & Stanghellini, V. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.059 · Cited by 2,418
Iversen, L. (2003) · Brain · doi:10.1093/brain/awg143 · Cited by 732
Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse
Allen, J. H., de Moore, G. M., Heddle, R., & Twartz, J. C. (2004) · Gut · doi:10.1136/gut.2003.036350 · Cited by 529
Camilleri, M., Dubois, D., Coulie, B., Jones, M., Kahrilas, P. J., Rentz, A. M., Sonnenberg, A., Stanghellini, V., Stewart, W. F., Tack, J., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00153-9 · Cited by 384
Cannabinoid Hyperemesis: A Case Series of 98 Patients
Simonetto, D. A., Oxentenko, A. S., Herman, M. L., & Szostek, J. H. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.10.005 · Cited by 327
Cannabinoid Hyperemesis Syndrome
A. Galli, J., Andari Sawaya, R., & K. Friedenberg, F. (2011) · Current Drug Abuse Reviewse · doi:10.2174/1874473711104040241 · Cited by 303
Ford, A. C., Forman, D., Bailey, A. G., Axon, A. T. R., & Moayyedi, P. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01740.x · Cited by 233
Self-citationCyclic Vomiting Syndrome in 41 adults: the illness, the patients, and problems of management
Fleisher, D. R., Gornowicz, B., Adams, K., Burch, R., & Feldman, E. J. (2005) · BMC Medicine · doi:10.1186/1741-7015-3-20 · Cited by 215
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects
Izzo, A. A., & Camilleri, M. (2008) · Gut · doi:10.1136/gut.2008.148791 · Cited by 199
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system
Sharkey, K. A., Darmani, N. A., & Parker, L. A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.068 · Cited by 195
Research works printed but not linked: 1
- 10.1097/00005176-199511000-00014 · doi:10.1097/00005176-199511000-00014 · Paper page
Cited by
Venkatesan, T., Levinthal, D. J., Tarbell, S. E., Jaradeh, S. S., Hasler, W. L., Issenman, R. M., Adams, K. A., Sarosiek, I., Stave, C. D., Sharaf, R. N., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13604 · Cited by 137
Cannabis hyperemesis syndrome: an update on the pathophysiology and management
Perisetti, A., Gajendran, M., Dasari, C. S., Bansal, P., Aziz, M., Inamdar, S., Tharian, B., & Goyal, H. (2020) · Annals of Gastroenterology · doi:10.20524/aog.2020.0528 · Cited by 85
Cyclic Vomiting Syndrome in Children
Raucci, U., Borrelli, O., Nardo, G. D., Tambucci, R., Pavone, P., Salvatore, S., Baldassarre, M. E., Cordelli, D. M., Falsaperla, R., Felici, E., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.583425 · Cited by 80
Sagar, R. C., Sood, R., Gracie, D. J., Gold, M. J., To, N., Law, G. R., & Ford, A. C. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13174 · Cited by 64
Self-citationMeade, E., & Garvey, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158574 · Cited by 57
“Some hypothesise that CVS is due to psychological or infectious triggers causing alterations or neuroendocrine dysfunction of the gut–brain pathway and activation of the CRF system [121].”
Background
Metadata
- Authors
- Shearer, J., Luthra, P., & Ford, A. C.
- Affiliations
- St James's University Hospital (GB)
- University of Leeds (GB)
- Corresponding author
- Ford, Alexander C
- Venue
- Frontline Gastroenterology
- Publisher
- BMJ
- Published
- 2016-05-27
- Volume
- 9
- Issue
- 1
- Pages
- 2-9
- ISSN
- 2041-4137 (ISSN-L)
- 2041-4145
- PMC
- PMC5824764
- OpenAlex
- W2403316333
- Cited by
- 23
- References
- 66
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 2
- FWCI
- 0.53
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Frontline Gastroenterology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Keywords
- cyclic vomiting syndrome, amitriptyline, cannabis use, delayed diagnosis, neuroendocrine dysfunction, mitochondrial DNA mutations, tricyclic antidepressants, prophylaxis, antiemetics, adult patients
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclic vomiting syndrome: a case series and review of the literature. https://app.cochat.ai/papers/10.1136/flgastro-2016-100705
- The paper
- Shearer, J., Luthra, P., & Ford, A. C. (2018). Cyclic vomiting syndrome: a case series and review of the literature. Frontline Gastroenterology. https://doi.org/10.1136/flgastro-2016-100705
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.